Stefanos Kalomoiris

发表

Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.

J. Nolta, G. Bauer, S. Olson, 2010, Advanced drug delivery reviews.

CD25 preselective anti-HIV vectors for improved HIV gene therapy.

J. Nolta, G. Bauer, Joseph S Anderson, 2012, Human gene therapy methods.

FGF2 Induces Migration of Human Bone Marrow Stromal Cells by Increasing Core Fucosylations on N-Glycans of Integrins

C. Lebrilla, M. Allende, Gege Xu, 2018, Stem cell reports.

Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow‐Derived Mesenchymal Stem Cells

J. Nolta, F. Fierro, Stefanos Kalomoiris, 2016, Journal of cellular biochemistry.

Effects on Proliferation and Differentiation of Multipotent Bone Marrow Stromal Cells Engineered to Express Growth Factors for Combined Cell and Gene Therapy

J. Nolta, F. Fierro, Claus Sondergaard, 2011, Stem cells.

Hypoxic Preconditioning of Mesenchymal Stromal Cells Induces Metabolic Changes, Enhances Survival, and Promotes Cell Retention In Vivo

J. Nolta, R. Isseroff, J. Beegle, 2015, Stem cells.

Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.

Brian Fury, J. Nolta, G. Bauer, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin

J. Nolta, S. Olson, W. Cary, 2012, Molecular and Cellular Neuroscience.

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models

V. Wheelock, Brian Fury, J. Nolta, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Title Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington ' s Disease Mouse Models

V. Wheelock, Brian Fury, J. Nolta, 2016 .

Mesenchymal Stem Cells Respond to Hypoxia by Increasing Diacylglycerols

B. Merkely, J. Nolta, F. Fierro, 2016, Journal of cellular biochemistry.

Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells.

J. Nolta, S. Olson, Amal Kambal, 2011, Tissue engineering. Part A.

Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts

V. Wheelock, D. Segal, J. Nolta, 2016, Cell transplantation.

Concise Review: MicroRNA Function in Multipotent Mesenchymal Stromal Cells

J. Nolta, Jan A Nolta, Elizabeth A Clark, 2014, Stem cells.

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.

V. Wheelock, Brian Fury, J. Nolta, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Genetic monitoring and effects of stocking practices on small Cyprinus carpio populations

C. Triantaphyllidis, T. Abatzopoulos, A. Triantafyllidis, 2011, Conservation Genetics.

Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia

J. Nolta, P. Zhou, G. Annett, 2016, Molecular therapy. Methods & clinical development.

Stem Cell Repor ts Report FGF2 Induces Migration of Human Bone Marrow Stromal Cells by Increasing Core Fucosylations on N-Glycans of Integrins

C. Lebrilla, Gege Xu, Dayoung Park, 2022 .

Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin

J. Nolta, S. Olson, W. Cary, 2012, Molecular and Cellular Neuroscience.